Ymab investors have opportunity to lead y-mabs therapeutics, inc. securities fraud lawsuit

Los angeles , feb. 17, 2023 /prnewswire/ --  glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against y-mabs therapeutics, inc. ("y-mabs" or the "company") (nasdaq: ymab). class period: october 6, 2020 – october 28, 2022 lead plaintiff deadline: march 20, 2023 if you wish to serve as lead plaintiff of the y-mabs lawsuit, you can submit your contact information at www.glancylaw.com/cases/y-mabs-therapeutics-inc/.
YMAB Ratings Summary
YMAB Quant Ranking